KERX Related Analyst EPS View
-
Brean Reiterates Buy on Keryx Biopharmaceuticals (KERX)
-
Keryx Biopharmaceuticals (KERX) Selloff 'Unwarranted'
-
Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Opportunities for Zerenex
-
Brean Murray Maintains 'Buy' on Keryx (KERX); Focus Shifts to Less Risky Zerenex
Back to KERX Stock Lookup
